Addressing the urgency: advocating for the inclusion of meningococcal vaccine in Pakistan's immunization program. [PDF]
Ghouri H +4 more
europepmc +1 more source
Author Correction: A randomized study to evaluate the safety and immunogenicity of a pentavalent meningococcal vaccine. [PDF]
Kim Y +7 more
europepmc +1 more source
Immunogenicity of a Booster Dose of Quadrivalent Meningococcal Conjugate Vaccine in Previously Immunized HIV-Infected Children and Youth [PDF]
Meredith G. Warshaw +5 more
openalex +1 more source
Meningococcal vaccine 4CMenB elicits a robust cellular immune response that targets but is not consistently protective against <i>Neisseria gonorrhoeae</i> during murine vaginal infection. [PDF]
Zeppa JJ +7 more
europepmc +1 more source
Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. [PDF]
Collins JP +8 more
europepmc +1 more source
Persistence of antibodies in adolescents 18−24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine [PDF]
Marı́a Elena Santolaya +9 more
openalex +1 more source
The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection [PDF]
Ray Borrow +18 more
openalex +1 more source

